EMFLAZA
These highlights do not include all the information needed to use EMFLAZA safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA (deflazacort) tablets, for oral use EMFLAZA (deflazacort) oral suspension Initial U.S. Approval: 2017
31b347d2-f156-4055-9d8f-7cf0df420296
HUMAN PRESCRIPTION DRUG LABEL
Feb 21, 2023
PTC Therapeutics, Inc.
DUNS: 124371951
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
deflazacort
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
deflazacort
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
deflazacort
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
deflazacort
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
deflazacort
Product Details
FDA regulatory identification and product classification information